An Australian biotech is hoping for success with its attempt to turn a virus into a cancer fighter after its first patient was dosed in a Los Angeles hospital last month. Imugene chief executive Leslie ...
Join our mailing list to be on the front lines of healthcare , get exclusive content, and promos.